Unicycive Therapeutics (UNCY) PT Lowered to $23 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Kumaraguru Raja lowered the price target on Unicycive Therapeutics (NASDAQ: UNCY) to $23.00 (from $40.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
